Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.
Press releases published on July 1, 2025
GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire
·
July 1, 2025
Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety results demonstrated GRI-0621 to be safe and well- …
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants
GlobeNewswire
·
July 1, 2025
SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a placement …
Outlook Therapeutics Appoints Biopharmaceutical Industry and Commercial Leader Bob Jahr as Chief Executive Officer
GlobeNewswire
·
July 1, 2025
Well-established executive with over 20 years of experience building and leading commercial teams across diverse therapeutic markets and geographies Career focused on driving business growth and developing an integrated commercial strategy to deliver …
LET Mining launches cloud mining mobile app to generate daily income for users around the world
GlobeNewswire
·
July 1, 2025
London, UK, July 01, 2025 (GLOBE NEWSWIRE) -- With the rapid development of the digital economy, convenience has become the core trend for users to participate in the cryptocurrency ecosystem. In order to meet the needs of global users for convenience and …
T-knife Therapeutics Appoints Christoph Broja to its Board of Directors
GlobeNewswire
·
July 1, 2025
SAN FRANCISCO and BERLIN, July 01, 2025 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer, today announced the appointment of Christoph Broja, a …
TWL Miner Announces Advancements in AI-Powered Cloud Mining Infrastructure Following $95 Million Series B Funding
GlobeNewswire
·
July 1, 2025
Sheffield, South Yorkshire, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) -- TWL Miner, a UK-based cloud mining platform established in 2019, has announced the successful completion of its Series B funding round, securing $95 million to support the …
Verano to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 1, 2025
CHICAGO, July 01, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the second quarter ended …
Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli® (systemic pegcetacoplan)
GlobeNewswire
·
July 1, 2025
Apellis to receive $275 million upfront and up to $25 million in milestone payments upon EMA approval in C3G and IC-MPGN Non-dilutive financing further strengthens Apellis’ balance sheet Apellis retains full U.S. commercialization rights for systemic …
Parexel announces appointments of two FDA luminaries – Lola Fashoyin-Aje, M.D., MPH and Tala Fakhouri, Ph.D., MPH – to its Consulting team, further strengthening regulatory, medical and AI expertise
GlobeNewswire
·
July 1, 2025
DURHAM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced two Food and Drug …
atai Life Sciences Announces $50 Million Private Placement Financing
GlobeNewswire
·
July 1, 2025
NEW YORK and AMSTERDAM, July 01, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, today …
atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
GlobeNewswire
·
July 1, 2025
Study met its primary and all key secondary endpoints, and BPL-003 demonstrated rapid, robust and durable antidepressant effects with a single dose Both 8 mg and 12 mg single doses of BPL-003 showed statistically significant and clinically meaningful …
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
GlobeNewswire
·
July 1, 2025
MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced that a total of 38 patients were enrolled in newly diagnosed glioblastoma multiforme (TEM-GBM) study, with 25 patients …
Un estudio de BitMEX revela una caída del 90 % en las tasas de financiación de los futuros perpetuos de Bitcoin desde 2016 e indica la consolidación del mercado
GlobeNewswire
·
July 1, 2025
VICTORIA, Seychelles, July 01, 2025 (GLOBE NEWSWIRE) -- BitMEX, la plataforma de intercambio de criptomonedas más segura, ha anunciado hoy los resultados de su exhaustivo estudio sobre el XBTUSD, el swap perpetuo de Bitcoin más antiguo, con el fin de …
Commencement of Trading on OTCQX in the U.S.
GlobeNewswire
·
July 1, 2025
Reykjavík, July 01, 2025 (GLOBE NEWSWIRE) -- Amaroq Minerals Ltd. (“Amaroq” or the “Company”) Commencement of Trading on OTCQX in the U.S. TORONTO, ONTARIO – 1 July 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent mine …
Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants
GlobeNewswire
·
July 1, 2025
VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and …
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
GlobeNewswire
·
July 1, 2025
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required …
Western Uranium & Vanadium Announces Results of AGM and Appoints New Transfer Agent
GlobeNewswire
·
July 1, 2025
Toronto, Ontario and Nucla, Colorado, June 30, 2025 (GLOBE NEWSWIRE) -- Western Uranium …